Fleksi B12

Every 3 ml contains:

• Meloxicam BP 15 mg;
• Cyanocobalamin BP 5 mg;
• Betamethasone sodium phosphate BP equivalent to betamethasone 0.30 mg;
• Water for injection BP q.s.

Symptomatic treatment for:

• rheumatoid arthritis;
• inflammatory and degenerative diseases of the musculoskeletal system, such as arthropathy, dorsopathies (for example, sciatica, lumboischialgia, cervical brachialgia, brachial periarthritis, Reiter’s syndrome, ankylosing spondylitis (Bechterew’s disease), acute tenosynovitis), accompanied by pain;
• osteoarthritis (arthrosis, degenerative joint diseases), incl. with a pain component.

The drug is intended for symptomatic therapy, reducing pain and inflammation at the time of use, and does not affect the progression of the disease.

Parenterally used as initial therapy and short-term symptomatic treatment.

The drug is administered intramuscularly and the dosage is determined individually, based on the degree of pain and inflammation. It is not recommended to use simultaneously with other NSAIDs.

The maximum daily dose is 7.5-15 mg.
Intramuscular injections are used only in the first 2-3 days, after which treatment continues with oral forms.
The drug does not mix with other medications in the same syringe.
The usual dose of Flexi-B12 is 3 ml (1 ampoule) per day, injected into the upper outer sector of the gluteus maximus muscle.